Company Update (NYSE:A): Dako, an Agilent Technologies Company, Announces FDA Approval of New Companion Diagnostic for Lung Cancer

[Business Wire] – Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the U.S. Food and Drug Administration approval of a new companion diagnostic assay that can reveal . . . → Read More: Company Update (NYSE:A): Dako, an Agilent Technologies Company, Announces FDA Approval of New Companion Diagnostic for Lung Cancer Similar Articles: Company Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Reports Third-Quarter 2015 Results Company Update: Agilent Technologies Inc (NYSE:A) – TRADE NEWS: Agilent Technologies Raises Standard for Routine Elemental Analysis With New ICP-MS System Company Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Announces Cash Dividend of 10 Cents per Share